Loading company…
Veneno Technologies develops disulfide-rich peptides and screening methods for drug discovery.
Founded in 2020 and based in Ibaraki, Japan, Veneno Technologies develops disulfide-rich peptides targeting transmembrane proteins such as ion channels, transporters, and GPCRs. Its PERISS method uses evolutionary molecular engineering to select peptide candidates. The company says these peptides are stable and potent compared with linear peptides.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in